Matthew Korenberg - 30 Jun 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
PRESIDENT & CHIEF OPERATING
Signature
By: /s/ Andrew Reardon For: Matthew E. Korenberg
Issuer symbol
LGND
Transactions as of
30 Jun 2023
Transactions value $
$21,349
Form type
4
Filing time
10 Jul 2023, 18:42:48 UTC
Previous filing
27 Feb 2023
Next filing
06 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Other $21,349 +376 +0.38% $56.78 99,124 30 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).